EFNB2 and neoplasm: To conclude, our findings demonstrated that in OSCC cells overexpressing ephrin-B2, activation of the ephrin-B2 reverse signaling pathway in the tumor microenvironment facilitated progression and lymph node metastasis via enhancement of the malignant potential and interactions with surrounding tumor cells.